Method Of Treating Atrophic Vaginitis
First Claim
Patent Images
1. A pharmaceutical composition for the treatment of symptoms associated with atrophic vaginitis comprising:
- a therapeutically effective amount of a triphenylethylene derivative compound, wherein the triphenylethylene derivative acts as a selective estrogen receptor modulator, and a therapeutically effective amount of a suitable carrier for vaginal administration.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides novel pharmaceutical compositions containing triphenylethylene derivative compounds, and methods of using the composition for treatment of symptoms associated with atrophic vaginitis. The pharmaceutical compositions are prepared for the vaginal administration of triphenylethylene derivative compounds in single or combination therapies. Preferably, the triphenylethylene derivative is tamoxifen.
-
Citations
45 Claims
-
1. A pharmaceutical composition for the treatment of symptoms associated with atrophic vaginitis comprising:
- a therapeutically effective amount of a triphenylethylene derivative compound, wherein the triphenylethylene derivative acts as a selective estrogen receptor modulator, and a therapeutically effective amount of a suitable carrier for vaginal administration.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
- 20. A method of treating symptoms of atrophic vaginitis in a patient in need thereof, which comprises vaginally administering an effective amount of a triphenylethylene derivative compound, and wherein the patient is a hysterectomized patient.
- 21. A method of treating symptoms of atrophic vaginitis in a patient in need thereof, wherein the method comprises vaginally administering a therapeutically effective amount of a triphenylethylene derivative compound and a progesterone compound, wherein the patient is a non-hysterectomized patient.
Specification